| UniProt ID | SETB1_HUMAN | |
|---|---|---|
| UniProt AC | Q15047 | |
| Protein Name | Histone-lysine N-methyltransferase SETDB1 | |
| Gene Name | SETDB1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1291 | |
| Subcellular Localization | Nucleus. Chromosome. Associated with non-pericentromeric regions of chromatin. Excluded from nucleoli and islands of condensed chromatin. | |
| Protein Description | Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3. H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes. H3 'Lys-9' trimethylation is coordinated with DNA methylation. Probably forms a complex with MBD1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation. Its activity is dependent on MBD1 and is heritably maintained through DNA replication by being recruited by CAF-1. SETDB1 is targeted to histone H3 by TRIM28/TIF1B, a factor recruited by KRAB zinc-finger proteins. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells. [PubMed: 24623306 Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs)] | |
| Protein Sequence | MSSLPGCIGLDAATATVESEEIAELQQAVVEELGISMEELRHFIDEELEKMDCVQQRKKQLAELETWVIQKESEVAHVDQLFDDASRAVTNCESLVKDFYSKLGLQYRDSSSEDESSRPTEIIEIPDEDDDVLSIDSGDAGSRTPKDQKLREAMAALRKSAQDVQKFMDAVNKKSSSQDLHKGTLSQMSGELSKDGDLIVSMRILGKKRTKTWHKGTLIAIQTVGPGKKYKVKFDNKGKSLLSGNHIAYDYHPPADKLYVGSRVVAKYKDGNQVWLYAGIVAETPNVKNKLRFLIFFDDGYASYVTQSELYPICRPLKKTWEDIEDISCRDFIEEYVTAYPNRPMVLLKSGQLIKTEWEGTWWKSRVEEVDGSLVRILFLDDKRCEWIYRGSTRLEPMFSMKTSSASALEKKQGQLRTRPNMGAVRSKGPVVQYTQDLTGTGTQFKPVEPPQPTAPPAPPFPPAPPLSPQAGDSDLESQLAQSRKQVAKKSTSFRPGSVGSGHSSPTSPALSENVSGGKPGINQTYRSPLGSTASAPAPSALPAPPAPPVFHGMLERAPAEPSYRAPMEKLFYLPHVCSYTCLSRVRPMRNEQYRGKNPLLVPLLYDFRRMTARRRVNRKMGFHVIYKTPCGLCLRTMQEIERYLFETGCDFLFLEMFCLDPYVLVDRKFQPYKPFYYILDITYGKEDVPLSCVNEIDTTPPPQVAYSKERIPGKGVFINTGPEFLVGCDCKDGCRDKSKCACHQLTIQATACTPGGQINPNSGYQYKRLEECLPTGVYECNKRCKCDPNMCTNRLVQHGLQVRLQLFKTQNKGWGIRCLDDIAKGSFVCIYAGKILTDDFADKEGLEMGDEYFANLDHIESVENFKEGYESDAPCSSDSSGVDLKDQEDGNSGTEDPEESNDDSSDDNFCKDEDFSTSSVWRSYATRRQTRGQKENGLSETTSKDSHPPDLGPPHIPVPPSIPVGGCNPPSSEETPKNKVASWLSCNSVSEGGFADSDSHSSFKTNEGGEGRAGGSRMEAEKASTSGLGIKDEGDIKQAKKEDTDDRNKMSVVTESSRNYGYNPSPVKPEGLRRPPSKTSMHQSRRLMASAQSNPDDVLTLSSSTESEGESGTSRKPTAGQTSATAVDSDDIQTISSGSEGDDFEDKKNMTGPMKRQVAVKSTRGFALKSTHGIAIKSTNMASVDKGESAPVRKNTRQFYDGEESCYIIDAKLEGNLGRYLNHSCSPNLFVQNVFVDTHDLRFPWVAFFASKRIRAGTELTWDYNYEVGSVEGKELLCCCGAIECRGRLL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 58 | Ubiquitination | MDCVQQRKKQLAELE CHHHHHHHHHHHHHH | 40.30 | 22817900 | |
| 59 | Ubiquitination | DCVQQRKKQLAELET HHHHHHHHHHHHHHH | 53.37 | 22817900 | |
| 59 (in isoform 1) | Ubiquitination | - | 53.37 | 21890473 | |
| 59 (in isoform 2) | Ubiquitination | - | 53.37 | 21890473 | |
| 59 (in isoform 3) | Ubiquitination | - | 53.37 | 21890473 | |
| 94 | Phosphorylation | RAVTNCESLVKDFYS HHHHCHHHHHHHHHH | 40.43 | 25159151 | |
| 97 | Ubiquitination | TNCESLVKDFYSKLG HCHHHHHHHHHHHHC | 47.62 | 29967540 | |
| 102 | Ubiquitination | LVKDFYSKLGLQYRD HHHHHHHHHCCCCCC | 34.88 | 29967540 | |
| 107 | Phosphorylation | YSKLGLQYRDSSSED HHHHCCCCCCCCCCC | 22.79 | 21406692 | |
| 110 | Phosphorylation | LGLQYRDSSSEDESS HCCCCCCCCCCCCCC | 27.11 | 21406692 | |
| 111 | Phosphorylation | GLQYRDSSSEDESSR CCCCCCCCCCCCCCC | 41.87 | 21406692 | |
| 112 | Phosphorylation | LQYRDSSSEDESSRP CCCCCCCCCCCCCCC | 53.68 | 21406692 | |
| 116 | Phosphorylation | DSSSEDESSRPTEII CCCCCCCCCCCCEEE | 43.92 | 25137130 | |
| 117 | Phosphorylation | SSSEDESSRPTEIIE CCCCCCCCCCCEEEE | 39.99 | 25137130 | |
| 120 | Phosphorylation | EDESSRPTEIIEIPD CCCCCCCCEEEECCC | 38.41 | 25137130 | |
| 134 | Phosphorylation | DEDDDVLSIDSGDAG CCCCCCEECCCCCCC | 24.97 | 25137130 | |
| 137 | Phosphorylation | DDVLSIDSGDAGSRT CCCEECCCCCCCCCC | 36.58 | 25137130 | |
| 142 | Phosphorylation | IDSGDAGSRTPKDQK CCCCCCCCCCHHHHH | 34.40 | 21406692 | |
| 144 | Phosphorylation | SGDAGSRTPKDQKLR CCCCCCCCHHHHHHH | 36.07 | 21406692 | |
| 166 | Ubiquitination | KSAQDVQKFMDAVNK HHHHHHHHHHHHHHH | 42.37 | 29967540 | |
| 173 | Acetylation | KFMDAVNKKSSSQDL HHHHHHHHHCCCCHH | 47.65 | 7711297 | |
| 173 | Ubiquitination | KFMDAVNKKSSSQDL HHHHHHHHHCCCCHH | 47.65 | - | |
| 174 | Ubiquitination | FMDAVNKKSSSQDLH HHHHHHHHCCCCHHH | 50.82 | 29967540 | |
| 175 | Phosphorylation | MDAVNKKSSSQDLHK HHHHHHHCCCCHHHH | 36.51 | 22817900 | |
| 177 | Phosphorylation | AVNKKSSSQDLHKGT HHHHHCCCCHHHHCC | 34.50 | 29214152 | |
| 182 | Sumoylation | SSSQDLHKGTLSQMS CCCCHHHHCCHHHHH | 61.97 | 28112733 | |
| 182 | Ubiquitination | SSSQDLHKGTLSQMS CCCCHHHHCCHHHHH | 61.97 | 22817900 | |
| 189 | Phosphorylation | KGTLSQMSGELSKDG HCCHHHHHCCCCCCC | 22.83 | 28555341 | |
| 207 | Ubiquitination | VSMRILGKKRTKTWH EEEEECCCCCCCCCC | 35.32 | 32015554 | |
| 230 | Phosphorylation | TVGPGKKYKVKFDNK EECCCCEEEEEECCC | 25.21 | 22817900 | |
| 257 | Ubiquitination | DYHPPADKLYVGSRV CCCCCHHHEEEECEE | 43.77 | 29967540 | |
| 259 | Phosphorylation | HPPADKLYVGSRVVA CCCHHHEEEECEEEE | 14.43 | 20068231 | |
| 288 | Ubiquitination | VAETPNVKNKLRFLI EEECCCCCCCEEEEE | 55.81 | 30230243 | |
| 319 | Ubiquitination | PICRPLKKTWEDIED HHHHCCCCCHHCHHH | 67.56 | 29967540 | |
| 338 | Phosphorylation | DFIEEYVTAYPNRPM HHHHHHHHHCCCCCE | 21.41 | - | |
| 349 | Ubiquitination | NRPMVLLKSGQLIKT CCCEEEEECCCEEEE | 48.67 | 21963094 | |
| 350 | Phosphorylation | RPMVLLKSGQLIKTE CCEEEEECCCEEEEE | 31.57 | - | |
| 355 | Sumoylation | LKSGQLIKTEWEGTW EECCCEEEEEEECCC | 49.32 | - | |
| 355 | Sumoylation | LKSGQLIKTEWEGTW EECCCEEEEEEECCC | 49.32 | - | |
| 355 | Ubiquitination | LKSGQLIKTEWEGTW EECCCEEEEEEECCC | 49.32 | 21963094 | |
| 364 | Ubiquitination | EWEGTWWKSRVEEVD EEECCCHHHHEEEEC | 21.68 | - | |
| 383 | Ubiquitination | RILFLDDKRCEWIYR EEEEECCCCCEEEEC | 59.62 | - | |
| 400 | Phosphorylation | TRLEPMFSMKTSSAS CCCEECCCCCCCCCH | 17.08 | 24719451 | |
| 407 | Phosphorylation | SMKTSSASALEKKQG CCCCCCCHHHHHHCC | 35.02 | 21964256 | |
| 411 | Ubiquitination | SSASALEKKQGQLRT CCCHHHHHHCCCCCC | 51.77 | 29967540 | |
| 427 | Phosphorylation | PNMGAVRSKGPVVQY CCCCCCCCCCCEEEE | 35.05 | 23663014 | |
| 434 | Phosphorylation | SKGPVVQYTQDLTGT CCCCEEEEEECCCCC | 8.51 | 23663014 | |
| 435 | Phosphorylation | KGPVVQYTQDLTGTG CCCEEEEEECCCCCC | 9.87 | 23663014 | |
| 439 | Phosphorylation | VQYTQDLTGTGTQFK EEEEECCCCCCCCCC | 40.77 | 23663014 | |
| 441 | Phosphorylation | YTQDLTGTGTQFKPV EEECCCCCCCCCCCC | 31.64 | 23663014 | |
| 443 | Phosphorylation | QDLTGTGTQFKPVEP ECCCCCCCCCCCCCC | 30.58 | 23663014 | |
| 468 | Phosphorylation | FPPAPPLSPQAGDSD CCCCCCCCCCCCCCH | 22.27 | 26074081 | |
| 474 | Phosphorylation | LSPQAGDSDLESQLA CCCCCCCCHHHHHHH | 43.08 | 22817900 | |
| 490 | Trimethylation | SRKQVAKKSTSFRPG HHHHHHHHCCCCCCC | 49.59 | - | |
| 490 | Methylation | SRKQVAKKSTSFRPG HHHHHHHHCCCCCCC | 49.59 | 23644510 | |
| 491 | Phosphorylation | RKQVAKKSTSFRPGS HHHHHHHCCCCCCCC | 28.69 | 22496350 | |
| 492 | Phosphorylation | KQVAKKSTSFRPGSV HHHHHHCCCCCCCCC | 40.54 | 23312004 | |
| 493 | Phosphorylation | QVAKKSTSFRPGSVG HHHHHCCCCCCCCCC | 26.75 | 23312004 | |
| 495 | Methylation | AKKSTSFRPGSVGSG HHHCCCCCCCCCCCC | 34.14 | 115916537 | |
| 498 | Phosphorylation | STSFRPGSVGSGHSS CCCCCCCCCCCCCCC | 26.45 | 27732954 | |
| 501 | Phosphorylation | FRPGSVGSGHSSPTS CCCCCCCCCCCCCCC | 31.04 | 27732954 | |
| 504 | Phosphorylation | GSVGSGHSSPTSPAL CCCCCCCCCCCCHHH | 41.35 | 22496350 | |
| 505 | Phosphorylation | SVGSGHSSPTSPALS CCCCCCCCCCCHHHC | 26.90 | 27732954 | |
| 507 | Phosphorylation | GSGHSSPTSPALSEN CCCCCCCCCHHHCCC | 49.65 | 27732954 | |
| 508 | Phosphorylation | SGHSSPTSPALSENV CCCCCCCCHHHCCCC | 16.15 | 27732954 | |
| 512 | Phosphorylation | SPTSPALSENVSGGK CCCCHHHCCCCCCCC | 29.27 | 27732954 | |
| 516 | Phosphorylation | PALSENVSGGKPGIN HHHCCCCCCCCCCCC | 54.10 | 27732954 | |
| 525 | Phosphorylation | GKPGINQTYRSPLGS CCCCCCCCCCCCCCC | 19.20 | 25627689 | |
| 528 | Phosphorylation | GINQTYRSPLGSTAS CCCCCCCCCCCCCCC | 17.67 | 29255136 | |
| 532 | Phosphorylation | TYRSPLGSTASAPAP CCCCCCCCCCCCCCC | 28.60 | 29255136 | |
| 533 | Phosphorylation | YRSPLGSTASAPAPS CCCCCCCCCCCCCCC | 23.88 | 29255136 | |
| 535 | Phosphorylation | SPLGSTASAPAPSAL CCCCCCCCCCCCCCC | 34.57 | 29255136 | |
| 540 | Phosphorylation | TASAPAPSALPAPPA CCCCCCCCCCCCCCC | 44.54 | 27080861 | |
| 570 | Ubiquitination | SYRAPMEKLFYLPHV CCCCCHHHHHCCHHH | 37.33 | - | |
| 579 | Phosphorylation | FYLPHVCSYTCLSRV HCCHHHHHHHHHHCC | 23.53 | 24719451 | |
| 597 | Ubiquitination | RNEQYRGKNPLLVPL CCHHHCCCCCCHHHH | 46.52 | 21963094 | |
| 597 (in isoform 1) | Ubiquitination | - | 46.52 | 21890473 | |
| 597 (in isoform 3) | Ubiquitination | - | 46.52 | 21890473 | |
| 598 | Ubiquitination | NEQYRGKNPLLVPLL CHHHCCCCCCHHHHH | 34.96 | 21890473 | |
| 620 | Acetylation | ARRRVNRKMGFHVIY HHHHHHHHCCEEEEE | 37.87 | 26051181 | |
| 627 | Phosphorylation | KMGFHVIYKTPCGLC HCCEEEEEECCCCHH | 14.02 | - | |
| 628 | Acetylation | MGFHVIYKTPCGLCL CCEEEEEECCCCHHH | 34.56 | 26051181 | |
| 673 | Phosphorylation | VDRKFQPYKPFYYIL ECCCCCCCCCEEEEE | 22.10 | - | |
| 677 | Phosphorylation | FQPYKPFYYILDITY CCCCCCEEEEEECCC | 9.72 | - | |
| 678 | Phosphorylation | QPYKPFYYILDITYG CCCCCEEEEEECCCC | 8.72 | - | |
| 699 | Phosphorylation | SCVNEIDTTPPPQVA HHEEECCCCCCCCEE | 47.03 | 25627689 | |
| 700 | Phosphorylation | CVNEIDTTPPPQVAY HEEECCCCCCCCEEC | 30.01 | 25627689 | |
| 715 | Neddylation | SKERIPGKGVFINTG CCCCCCCCCEEEECC | 46.69 | 32015554 | |
| 715 | Ubiquitination | SKERIPGKGVFINTG CCCCCCCCCEEEECC | 46.69 | 32015554 | |
| 716 | Neddylation | KERIPGKGVFINTGP CCCCCCCCEEEECCC | 26.03 | 32015554 | |
| 716 | Ubiquitination | KERIPGKGVFINTGP CCCCCCCCEEEECCC | 26.03 | 32015554 | |
| 732 | Ubiquitination | FLVGCDCKDGCRDKS CEECCCCCCCCCCCC | 43.85 | 32015554 | |
| 733 | Ubiquitination | LVGCDCKDGCRDKSK EECCCCCCCCCCCCC | 68.69 | 32015554 | |
| 779 | Phosphorylation | ECLPTGVYECNKRCK HHCCCCHHHCCCCCC | 18.99 | 25159151 | |
| 786 | Acetylation | YECNKRCKCDPNMCT HHCCCCCCCCCCCHH | 45.78 | 19824909 | |
| 786 | Ubiquitination | YECNKRCKCDPNMCT HHCCCCCCCCCCCHH | 45.78 | - | |
| 809 | Acetylation | QVRLQLFKTQNKGWG HHHHHHEECCCCCCC | 58.77 | 24471143 | |
| 809 | Ubiquitination | QVRLQLFKTQNKGWG HHHHHHEECCCCCCC | 58.77 | - | |
| 813 | Ubiquitination | QLFKTQNKGWGIRCL HHEECCCCCCCEEEH | 46.34 | 29967540 | |
| 838 | Phosphorylation | IYAGKILTDDFADKE EECCCEECCCCCCHH | 36.68 | 16097034 | |
| 862 | Phosphorylation | ANLDHIESVENFKEG HCCHHHHHHHHHHCC | 33.84 | 22817900 | |
| 867 | Sumoylation | IESVENFKEGYESDA HHHHHHHHCCCCCCC | 62.91 | - | |
| 867 | Ubiquitination | IESVENFKEGYESDA HHHHHHHHCCCCCCC | 62.91 | - | |
| 872 | Phosphorylation | NFKEGYESDAPCSSD HHHCCCCCCCCCCCC | 30.50 | 25159151 | |
| 877 | Phosphorylation | YESDAPCSSDSSGVD CCCCCCCCCCCCCCC | 35.80 | 25627689 | |
| 878 | Phosphorylation | ESDAPCSSDSSGVDL CCCCCCCCCCCCCCC | 48.50 | 25627689 | |
| 880 | Phosphorylation | DAPCSSDSSGVDLKD CCCCCCCCCCCCCCC | 30.82 | 25627689 | |
| 905 | Phosphorylation | PEESNDDSSDDNFCK CCCCCCCCCCCCCCC | 38.23 | 22817900 | |
| 906 | Phosphorylation | EESNDDSSDDNFCKD CCCCCCCCCCCCCCC | 56.85 | 22817900 | |
| 917 | Phosphorylation | FCKDEDFSTSSVWRS CCCCCCCCHHHHHHH | 39.44 | 25159151 | |
| 918 | Phosphorylation | CKDEDFSTSSVWRSY CCCCCCCHHHHHHHH | 25.64 | 25159151 | |
| 919 | Phosphorylation | KDEDFSTSSVWRSYA CCCCCCHHHHHHHHH | 22.99 | 27732954 | |
| 920 | Phosphorylation | DEDFSTSSVWRSYAT CCCCCHHHHHHHHHH | 26.28 | 25159151 | |
| 972 | Phosphorylation | VGGCNPPSSEETPKN CCCCCCCCCCCCCCC | 52.19 | 25627689 | |
| 973 | Phosphorylation | GGCNPPSSEETPKNK CCCCCCCCCCCCCCC | 45.27 | 25627689 | |
| 976 | Phosphorylation | NPPSSEETPKNKVAS CCCCCCCCCCCCCCH | 35.20 | 25159151 | |
| 983 | Phosphorylation | TPKNKVASWLSCNSV CCCCCCCHHHCCCCC | 31.38 | 23312004 | |
| 986 | Phosphorylation | NKVASWLSCNSVSEG CCCCHHHCCCCCCCC | 12.66 | 23312004 | |
| 991 | Phosphorylation | WLSCNSVSEGGFADS HHCCCCCCCCCCCCC | 30.28 | 30576142 | |
| 998 | Phosphorylation | SEGGFADSDSHSSFK CCCCCCCCCCCCCCC | 37.27 | 24247654 | |
| 1000 | Phosphorylation | GGFADSDSHSSFKTN CCCCCCCCCCCCCCC | 29.26 | 30576142 | |
| 1002 | Phosphorylation | FADSDSHSSFKTNEG CCCCCCCCCCCCCCC | 41.23 | 23312004 | |
| 1003 | Phosphorylation | ADSDSHSSFKTNEGG CCCCCCCCCCCCCCC | 25.91 | 30576142 | |
| 1004 | Phosphorylation | DSDSHSSFKTNEGGE CCCCCCCCCCCCCCC | 14.69 | 33259812 | |
| 1006 | Phosphorylation | DSHSSFKTNEGGEGR CCCCCCCCCCCCCCC | 36.17 | 23312004 | |
| 1017 | Phosphorylation | GEGRAGGSRMEAEKA CCCCCCCCHHHHHHH | 27.77 | 22985185 | |
| 1025 | Phosphorylation | RMEAEKASTSGLGIK HHHHHHHHCCCCCCC | 33.89 | 20873877 | |
| 1026 | Phosphorylation | MEAEKASTSGLGIKD HHHHHHHCCCCCCCC | 31.51 | 20873877 | |
| 1027 | Phosphorylation | EAEKASTSGLGIKDE HHHHHHCCCCCCCCC | 29.53 | 20873877 | |
| 1032 | Sumoylation | STSGLGIKDEGDIKQ HCCCCCCCCCCCHHH | 48.18 | - | |
| 1032 | Acetylation | STSGLGIKDEGDIKQ HCCCCCCCCCCCHHH | 48.18 | 26051181 | |
| 1032 | Sumoylation | STSGLGIKDEGDIKQ HCCCCCCCCCCCHHH | 48.18 | 28112733 | |
| 1038 | Sumoylation | IKDEGDIKQAKKEDT CCCCCCHHHHHHHCC | 49.28 | 28112733 | |
| 1042 | Ubiquitination | GDIKQAKKEDTDDRN CCHHHHHHHCCCCCC | 64.93 | - | |
| 1045 | Phosphorylation | KQAKKEDTDDRNKMS HHHHHHCCCCCCCCE | 40.67 | - | |
| 1050 | Ubiquitination | EDTDDRNKMSVVTES HCCCCCCCCEEEECC | 33.18 | - | |
| 1055 | Phosphorylation | RNKMSVVTESSRNYG CCCCEEEECCCCCCC | 28.17 | 20068231 | |
| 1057 | Phosphorylation | KMSVVTESSRNYGYN CCEEEECCCCCCCCC | 25.82 | 20068231 | |
| 1058 | Phosphorylation | MSVVTESSRNYGYNP CEEEECCCCCCCCCC | 20.50 | 28555341 | |
| 1061 | Phosphorylation | VTESSRNYGYNPSPV EECCCCCCCCCCCCC | 21.63 | 23927012 | |
| 1063 | Phosphorylation | ESSRNYGYNPSPVKP CCCCCCCCCCCCCCC | 17.34 | 22167270 | |
| 1066 | Phosphorylation | RNYGYNPSPVKPEGL CCCCCCCCCCCCCCC | 38.39 | 22167270 | |
| 1066 (in isoform 3) | Phosphorylation | - | 38.39 | - | |
| 1067 | Phosphorylation | NYGYNPSPVKPEGLR CCCCCCCCCCCCCCC | 39.13 | 32645325 | |
| 1069 | Sumoylation | GYNPSPVKPEGLRRP CCCCCCCCCCCCCCC | 40.51 | - | |
| 1069 | Acetylation | GYNPSPVKPEGLRRP CCCCCCCCCCCCCCC | 40.51 | 26051181 | |
| 1069 | Sumoylation | GYNPSPVKPEGLRRP CCCCCCCCCCCCCCC | 40.51 | 28112733 | |
| 1078 | Phosphorylation | EGLRRPPSKTSMHQS CCCCCCCCCCCHHHH | 51.77 | 24719451 | |
| 1080 | Phosphorylation | LRRPPSKTSMHQSRR CCCCCCCCCHHHHHH | 35.30 | 20860994 | |
| 1081 | Phosphorylation | RRPPSKTSMHQSRRL CCCCCCCCHHHHHHH | 20.29 | 20860994 | |
| 1085 | Phosphorylation | SKTSMHQSRRLMASA CCCCHHHHHHHHHHH | 12.51 | 20860994 | |
| 1101 | Phosphorylation | SNPDDVLTLSSSTES CCCCCEEEEECCCCC | 25.17 | 22817900 | |
| 1103 | Phosphorylation | PDDVLTLSSSTESEG CCCEEEEECCCCCCC | 19.60 | 22817900 | |
| 1104 | Phosphorylation | DDVLTLSSSTESEGE CCEEEEECCCCCCCC | 44.38 | 22817900 | |
| 1106 | Phosphorylation | VLTLSSSTESEGESG EEEEECCCCCCCCCC | 45.54 | 22817900 | |
| 1108 | Phosphorylation | TLSSSTESEGESGTS EEECCCCCCCCCCCC | 51.49 | 22817900 | |
| 1112 | Phosphorylation | STESEGESGTSRKPT CCCCCCCCCCCCCCC | 59.22 | 22210691 | |
| 1119 | Phosphorylation | SGTSRKPTAGQTSAT CCCCCCCCCCCCCCE | 46.59 | 25072903 | |
| 1123 | Phosphorylation | RKPTAGQTSATAVDS CCCCCCCCCCEEECH | 21.29 | 21406692 | |
| 1124 | Phosphorylation | KPTAGQTSATAVDSD CCCCCCCCCEEECHH | 18.74 | 21406692 | |
| 1126 | Phosphorylation | TAGQTSATAVDSDDI CCCCCCCEEECHHHC | 27.29 | 21406692 | |
| 1130 | Phosphorylation | TSATAVDSDDIQTIS CCCEEECHHHCCEEC | 30.50 | 20363803 | |
| 1135 | Phosphorylation | VDSDDIQTISSGSEG ECHHHCCEECCCCCC | 24.14 | 25072903 | |
| 1137 | Phosphorylation | SDDIQTISSGSEGDD HHHCCEECCCCCCCC | 31.84 | 25072903 | |
| 1138 | Phosphorylation | DDIQTISSGSEGDDF HHCCEECCCCCCCCC | 42.35 | 25072903 | |
| 1140 | Phosphorylation | IQTISSGSEGDDFED CCEECCCCCCCCCCC | 40.11 | 25072903 | |
| 1149 | Sumoylation | GDDFEDKKNMTGPMK CCCCCCCCCCCCCCH | 65.36 | - | |
| 1149 | Sumoylation | GDDFEDKKNMTGPMK CCCCCCCCCCCCCCH | 65.36 | 28112733 | |
| 1152 | Phosphorylation | FEDKKNMTGPMKRQV CCCCCCCCCCCHHEE | 47.75 | 20860994 | |
| 1162 | Methylation | MKRQVAVKSTRGFAL CHHEEEEEECCCEEE | 36.05 | 83136539 | |
| 1163 | Phosphorylation | KRQVAVKSTRGFALK HHEEEEEECCCEEEE | 19.41 | - | |
| 1170 | "N6,N6,N6-trimethyllysine" | STRGFALKSTHGIAI ECCCEEEEECCEEEE | 50.29 | - | |
| 1170 | Methylation | STRGFALKSTHGIAI ECCCEEEEECCEEEE | 50.29 | 24129315 | |
| 1178 | "N6,N6,N6-trimethyllysine" | STHGIAIKSTNMASV ECCEEEEEECCCCCC | 42.05 | - | |
| 1178 | Methylation | STHGIAIKSTNMASV ECCEEEEEECCCCCC | 42.05 | 24129315 | |
| 1178 | Ubiquitination | STHGIAIKSTNMASV ECCEEEEEECCCCCC | 42.05 | 29967540 | |
| 1179 | Phosphorylation | THGIAIKSTNMASVD CCEEEEEECCCCCCC | 20.92 | 23312004 | |
| 1180 | Phosphorylation | HGIAIKSTNMASVDK CEEEEEECCCCCCCC | 24.82 | 22817900 | |
| 1180 (in isoform 3) | Phosphorylation | - | 24.82 | - | |
| 1184 | Phosphorylation | IKSTNMASVDKGESA EEECCCCCCCCCCCC | 21.78 | 23312004 | |
| 1187 | Ubiquitination | TNMASVDKGESAPVR CCCCCCCCCCCCCCC | 63.52 | 29967540 | |
| 1190 | Phosphorylation | ASVDKGESAPVRKNT CCCCCCCCCCCCCCC | 46.68 | 20068231 | |
| 1190 (in isoform 3) | Phosphorylation | - | 46.68 | - | |
| 1197 | Phosphorylation | SAPVRKNTRQFYDGE CCCCCCCCCCEECCC | 28.96 | 20068231 | |
| 1197 (in isoform 3) | Phosphorylation | - | 28.96 | - | |
| 1271 | Phosphorylation | DYNYEVGSVEGKELL ECCCCCCCCCCCEEE | 23.36 | 27251275 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SETB1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SETB1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1066, AND MASSSPECTROMETRY. | |
| "Quantitative analysis of global ubiquitination in HeLa cells by massspectrometry."; Meierhofer D., Wang X., Huang L., Kaiser P.; J. Proteome Res. 7:4566-4576(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-175, UBIQUITINATION[LARGE SCALE ANALYSIS] AT LYS-182, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1066, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1179; THR-1180 ANDSER-1190, AND MASS SPECTROMETRY. | |
| "Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC."; Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.; Proteomics 5:3589-3599(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-838, AND MASSSPECTROMETRY. | |
| Ubiquitylation | |
| Reference | PubMed |
| "Quantitative analysis of global ubiquitination in HeLa cells by massspectrometry."; Meierhofer D., Wang X., Huang L., Kaiser P.; J. Proteome Res. 7:4566-4576(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-175, UBIQUITINATION[LARGE SCALE ANALYSIS] AT LYS-182, AND MASS SPECTROMETRY. | |